Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
40.55
-0.50 (-1.22%)
Sep 24, 2026, 9:37 AM EDT - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $4.4 billion as of September 24, 2026. Its market cap has increased by 193.16% in one year.
Market Cap
4.40B
Enterprise Value
3.95B
1-Year Change
193.16%
Ranking
Category
Stock Price
$40.55
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $4.40B, an increase of 478.64%. That is a compound annual growth rate of 37.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 4.83B | 84.00% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 5.51B |
| Dianthus Therapeutics | 5.50B |
| Erasca | 5.44B |
| Definium Therapeutics | 5.42B |
| Veradermics | 4.94B |
| Iovance Biotherapeutics | 4.82B |
| Viking Therapeutics | 4.77B |
| Parabilis Medicines | 4.72B |